Immusan T, Inc. announced it raised $19.9 Million in an initial filing from an offering of $39.9 Million

Nov 14, 2017•about 8 years ago

Amount Raised

$19.9 Million

CambridgeBiotechnology

Company Information

Company

ImmusanT, Inc.

Location

One Kendall Square

Cambridge, Maryland, United States

About

ImmusanT is a biotechnology company developing diagnostics and therapeutics for the diagnosis and treatment of celiac disease.

6 contacts

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech